Rankings
▼
Calendar
PRAX Q4 2019 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena
PRAX
Praxis Precision Medicines, Inc.
$6B
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$-68.71
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$158,000
Balance Sheet
Total Assets
$48M
Total Liabilities
$8M
Stockholders' Equity
$40M
Cash & Equivalents
$45M
← FY 2019
All Quarters
Q1 2020 →
